sb 203580 has been researched along with 4-phenylenediamine in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (4-phenylenediamine) | Trials (4-phenylenediamine) | Recent Studies (post-2010) (4-phenylenediamine) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 873 | 9 | 301 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SC; Chye, SM; Koh, RY; Len, YW; Ng, KY; Ranjit, de A; Seow, HF; Tiong, YL; Yip, WK | 1 |
1 other study(ies) available for sb 203580 and 4-phenylenediamine
| Article | Year |
|---|---|
Apoptosis induced by para-phenylenediamine involves formation of ROS and activation of p38 and JNK in chang liver cells.
Topics: Apoptosis; Cell Line; Enzyme Activation; Humans; Imidazoles; Liver; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Phenylenediamines; Phosphorylation; Pyridines | 2014 |